| Dr Christopher Blake Myers, MD | |
|
1109 W Cumberland Rd, Ste 2, Bluefield, WV 24701-4562 | |
| (304) 327-8128 | |
| Not Available |
| Full Name | Dr Christopher Blake Myers |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 1109 W Cumberland Rd, Bluefield, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023088770 | NPI | - | NPPES |
| 140234 | Medicaid | SC | |
| 4328801 | Other | SC | AETNA PROVIDER NUMBER |
| 1577695003 | Other | SC | CIGNA PROVIDER NUMBER |
| 180018442 | Other | SC | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 29367 (West Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shasta Eye Medical Group Inc | 6002817590 | 7 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.
The Global Antibiotic Research and Development Partnership, the Clinton Health Access Initiative and Shionogi & Co., Ltd today announced a Memorandum of Understanding to accelerate access, including in low- and middle-income countries, to the antibiotic cefiderocol for bacterial infections in patients with limited treatment options.
Latest figures show that more Americans are turning to the emergency room for routine dental problems. This choice often costs 10 times more than preventive care and offers far fewer treatment options than a dentist's office. This comes from an analysis of government data and dental research.
› Verified 8 days ago
| Entity Name | Shasta Eye Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235603 PECOS PAC ID: 6002817590 Enrollment ID: O20070125000606 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.
The Global Antibiotic Research and Development Partnership, the Clinton Health Access Initiative and Shionogi & Co., Ltd today announced a Memorandum of Understanding to accelerate access, including in low- and middle-income countries, to the antibiotic cefiderocol for bacterial infections in patients with limited treatment options.
Latest figures show that more Americans are turning to the emergency room for routine dental problems. This choice often costs 10 times more than preventive care and offers far fewer treatment options than a dentist's office. This comes from an analysis of government data and dental research.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Blake Myers, MD 1109 W Cumberland Rd, Ste 2, Bluefield, WV 24701-4562 Ph: (304) 327-8128 | Dr Christopher Blake Myers, MD 1109 W Cumberland Rd, Ste 2, Bluefield, WV 24701-4562 Ph: (304) 327-8128 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.
The Global Antibiotic Research and Development Partnership, the Clinton Health Access Initiative and Shionogi & Co., Ltd today announced a Memorandum of Understanding to accelerate access, including in low- and middle-income countries, to the antibiotic cefiderocol for bacterial infections in patients with limited treatment options.
Latest figures show that more Americans are turning to the emergency room for routine dental problems. This choice often costs 10 times more than preventive care and offers far fewer treatment options than a dentist's office. This comes from an analysis of government data and dental research.
› Verified 8 days ago
Stephen Hill Blaydes, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1109 W Cumberland Rd, Bluefield, WV 24701 Phone: 304-327-8128 Fax: 304-327-5912 | |
Yasier Kanawati, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 510 Cherry St, Suite 305, Bluefield, WV 24701 Phone: 304-325-5711 Fax: 304-327-1789 |